Characteristics of Antibiotic Use Among Older Adults with Respiratory Diseases at Puskesmas X in West Jakarta
DOI:
https://doi.org/10.58258/se787x65Abstract
The impact of respiratory diseases on the older population worldwide had become increasingly evident as the global population aged 65 years and older continued to grow. Problems related to medication use had been associated with increased morbidity and mortality, longer hospital stays, higher treatment costs, and reduced quality of life. The various respiratory conditions and diseases that could occur in older adults did not always require antibiotic treatment. This study aimed to describe the characteristics of antibiotic use among older adults with respiratory diseases at (Primary Healthcare Centre) Puskesmas X, West Jakarta. This study used a descriptive retrospective crosssectional design and analyzed secondary data obtained from the medical records of patients who met the study criteria at Puskesmas X, West Jakarta, in 2024 and 2025. A total of 285 medical records were analyzed, with a relatively balanced proportion of male and female patients. Six respiratory disease diagnoses were identified, with upper respiratory tract infections (acute pharyngitis, acute respiratory infection, common cold, and acute tonsillitis) accounting for the majority (85%), followed by chronic obstructive pulmonary disease (COPD) (12%), pneumonia (2%), and bronchitis (2%). Only two types of antibiotics were prescribed, namely amoxicillin and cefadroxil, with amoxicillin being predominant (92%). The most common treatment duration was 5 days (45%), followed by 3 days (11%) and 7 days (3%), while the duration was not documented in 42% of the medical records. In conclusion, antibiotic use among older adults with respiratory diseases at the Pusekesmas X was dominated by amoxicillin, particularly for upper respiratory tract infections. The high proportion of medical records without documented antibiotic treatment duration indicated a need to improve the quality of documentation of antibiotic prescribing and use.References
Kementerian Kesehatan, Polusi udara sebabkan angka penyakit respirasi tinggi. Accessed: Nov. 09, 2025. [Online]. Available: https://kemkes.go.id/id/polusi-udara-sebabkan-angka-penyakit-respirasi-tinggi
Joshi, P.R.(2024). Pulmonary Diseases in Older Patients: Understanding and Addressing the Challenges, Geriatr., vol. 9, no. 2. doi: 10.3390/geriatrics9020034.
Wesnawa, M.A.D.P., Subagiarta, I.M., and Nathania, E. (2025). Lung Aging and Lung Function Assessment in Elderly. J. Respi. Vol. 11 (01); 93-100, doi: 10.20473/jr.v11-I.1.2025.93-100
Beckett, C.L., Harbarth, S., and Huttner S. (2015). Special considerations of antibiotic prescription in the geriatric population. Clin. Microbiol. Infect., vol. 21, no. 1, p. 3. doi: 10.1016/j.cmi.2014.08.018
Theodorakis N et al.(2024). Antibiotic Resistance in the Elderly: Mechanisms, Risk Factors, and Solutions. Microorganisms, vol. 12, no. 10. doi: 10.3390/microorganisms12101978.
Ascher,K, Elliot, S.J., Rubio, G.A., Glassberg, M.K. (2017). Lung Diseases of the Elderly: Cellular Mechanisms. Clin. Geriatr. Med., vol. 33, no. 4, pp. 473–490. doi: 10.1016/j.cger.2017.07.001.
Mertosono, L, Ottay, R., and I. Siagian. (2024). Gambaran penyakit saluran pernapasandi Puskesmas Wenang Kecamatan Wenang Kota Manadoperiode Juli 2023 – Juni 2024.
J. Keperawatan, vol. 8, no. 1, p. 75.
Akhtar, A., Hassali, M.A.A., Zainal, A., Ali, I., Iqbal, M.I., Khan, A.H. (2021). Respiratory-tract infections among geriatrics: prevalence and factors associated with the treatment outcomes. Ther. Adv. Respir. Dis., vol. 15, pp. 1–9. doi: 10.1177/1753466620971141.
Geffen, L.(2006). Common upper respiratory tract problems in the elderly - A guide to clinical diagnosis and prudent prescription. South African Fam. Pract., vol. 48, no. 5, pp. 20–23. doi: 10.1080/20786204.2006.10873390.
BPPK.(2019). Laporan Nasional RISKESDAS 2018. Lembaga Penerbit Badan Penelitian dan Pengembangan Kesehatan.
BKPK.(2023). Survei Kesehatan Indonesia (SKI) 2023 Dalam Angka. BKPK
Vaz Fragoso, V.A.(2017). Epidemiology of Lung Disease in Older Persons. Clin. Geriatr. Med., vol. 33, no. 4, pp. 491–501. doi: 10.1016/j.cger.2017.06.003.
Nairz, M., Weiss, G.(2025). How to identify respiratory pathogens in primary health care - a review on the benefits, prospects and pitfalls in using point of care tests. Infection, vol. 53, no. 6, pp. 2321–2340. doi: 10.1007/s15010-025-02600-1.
Aronen, M. et al. (2019). Respiratory tract virus infections in the elderly with pneumonia. BMC Geriatr., vol. 19, no. 1, pp. 1–11. doi: 10.1186/s12877-019-1125-z.
Kementerian Kesehatan RI. (2019). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Penyakit Paru Obstruktif Kronik.
Häder, A. et al.(2024). Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention. Aging Dis., vol. 14, no. 4, pp. 1091–1104. doi: 10.14336/ad.2023.0329.
Wilson, H.L., Daveson, K., Del Mar, C.B. (2019). Optimal antimicrobial duration for common bacterial infections. Aust. Prescr., vol. 42, no. 1, pp. 5–9. doi: 10.18773/austprescr.2019.001.
Nurrohmah, A., Suri, N., Damayamti, E.(2025). Rasionalitas Penggunaan Antibiotik Pada Pasien Infeksi Saluran Pernapasan Akut (Ispa) Di Puskesmas. Sains Med., vol. 3, no. 5. [Online]. Available: homepage: https://wpcpublisher.com/jurnal/index.php/sainsmedisina
Limato,R. et al.(2022). Optimizing antibiotic use in Indonesia: A systematic review and evidence synthesis to inform opportunities for intervention. Lancet Reg. Heal. - Southeast Asia, vol. 2, no. 6. doi: 10.1016/j.lansea.2022.05.002.
Grant, J., Le Saux, N.(2021). Duration of antibiotic therapy for common infections. J. Assoc. Med. Microbiol. Infect. Dis. Canada, vol. 6, no. 3, pp. 181–197. doi: 10.3138/JAMMI-2021-04-29.
Downloads
Published
Issue
Section
License
Authors who publish with Research of Service Administration Health and Sains Healthys agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.Â
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
